Interestingly, co-secretion of FGF2, a potential stem cell growth factor, on PSA-secreting CTCs observed in a previous study that included PCA patients at more advanced stages20, was not found in this study, suggesting that CTCs in non-metastatic PCa patients might differ phenotypically from CTCs in advanced stage patients. Here, FGF2 is linked to posterior cortical atrophy.